NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis is an early-stage study to find a safe dose and see how well a new oral tablet called HSK47977 works for adults with non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Researchers will test different dose levels in about 110 participants to chec…
Matched conditions: NHL
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat lymphoma: adding a pill to standard chemo
Disease control Recruiting nowThis study is testing if adding a pill called acalabrutinib to standard chemotherapy can help more people with an aggressive type of blood cancer called diffuse large B-cell lymphoma (DLBCL). It is for adults who have not yet started any treatment for their lymphoma. Researchers …
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can yoga and mindfulness ease life after cancer?
Symptom relief Recruiting nowThis study is testing whether yoga and mindfulness training can help improve the quality of life for people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. Researchers will enroll 100 adult survivors who finished their main cancer treatments at least six months a…
Matched conditions: NHL
Phase: NA • Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC